human granulysin Search Results


93
Shanghai Korain Biotech Co Ltd human granulysin
Serum <t> granulysin </t> and cathepsin-L levels of the patient and control groups.
Human Granulysin, supplied by Shanghai Korain Biotech Co Ltd, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+granulysin/Human+Granulysin/pmc11111119-58-14-33
Average 93 stars, based on 1 article reviews
human granulysin - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier

94
R&D Systems human granulysin duoset elisa
a , Frequency of circulating lymphocytes from 8 healthy donors (HD) and 8 P. falciparum patients (Pf). CD3 + CD4 + (CD4), CD3 + CD8 + (CD8), CD3 + TCRδ2 + (γδ2), CD3 − CD56 + (NK). b , c , Circulating γδ2 T cell activation in 8 HD and 5 Pf was evaluated by CD69 and CD16 staining. d , Intracellular <t>granulysin</t> (GNLY), perforin (PFN) and granzyme B (GzmB) in 8 HD and 8 Pf. e , CFSE-stained iRBC were co-cultured with fresh purified γδ2 T cells from 3 HD and 3 Pf at indicated E:T ratios for 12 hr and iRBC lysis was assessed by flow cytometry analysis of the number of viable CFSE + cells relative to added counting beads. f , Plasma GNLY concentration in 16 HD and 22 Pf patients by GNLY <t>ELISA.</t> Statistical analysis was performed by two-tailed nonparametric unpaired t-test ( a,f ), two-way ANOVA with Sidak’s multiple comparisons test ( d ), and area under the curve, followed by two-tailed nonparametric paired t-test, followed by two-tailed nonparametric paired t-test ( e ). Mean ± s.e.m. is shown. P value: *<0.05, **<0.01, ***<0.001, ****<0.0001.
Human Granulysin Duoset Elisa, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+granulysin/Human+Granulysin+DuoSet+ELISA/pmc07906917-207-12-16
Average 94 stars, based on 1 article reviews
human granulysin duoset elisa - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier

93
R&D Systems granulysin
A: BCP-ALL cells in the presence (red) or absence (grey) of BLN for three days were co-cultured with freshly isolated γδ, CD4⁺ and CD8⁺ αβ T cells/ T- and B-cell frequencies in the coculture were assessed by staining for CD3 and CD19, as exemplary shown for CD8⁺ αβ T cells. B: The release of IFNγ, GrzB and Prf into supernatants of cocultures in the presence (red) or absence (grey) of BLN was assessed via ELISA after three days, and the release of <t>Gnly</t> was analyzed after seven days. Data includes 4 to 7 healthy donors and * indicates p value between 0.01-0.05, ** indicates p value between 0.01-0.001 (paired and unpaired T-test).
Granulysin, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+granulysin/Human+Granulysin+DuoSet+ELISA/bio_rxiv__2025__11__17__688178-54-15-31
Average 93 stars, based on 1 article reviews
granulysin - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier

91
R&D Systems human granulysin
FIGURE 4. Expression of cytotoxic granules’ components (mRNA and protein) by NK cells. (A–D) Analysis by qRT-PCR of the mRNA relative ex- pression for granzyme A (A), granzyme B (B), perforin (C), and <t>granulysin</t> (D) in NK cells isolated from peripheral blood of controls (n = 9) unstimulated (US), stimulated with IL-15 (5 ng/ml) or with P. brasiliensis yeast cells (strains Pb18 or Pb265; yeast cell/NK cell ratio 1:100) for 24 h. Results are expressed as mean 6 SEM of the relative expression determined as described in Materials and Methods. Statistical analysis: ANOVA for repeated measures with Bonferroni posttest. *p # 0.05 (in relation to unstimulated cells), #p # 0.05 (in relation to IL-15–stimulated cells). (E–H) Flow cytometry analysis of the expression of granzyme A (E), granzyme B (F), perforin (G), and granulysin (H) in NK cells isolated from peripheral blood of controls (n = 10) and PCM patients (n = 7) unstimulated (US), stimulated with IL-15 (5 ng/ml) or with P. brasiliensis yeast cells (strains Pb18 or Pb265; yeast cell/NK cell ratio 1:100) for 24 h. Results are expressed as mean 6 SEM of the percentage of positive cells for each parameter. Statistical analysis: ANOVA for repeated measures with Bonferroni posttest. #p # 0.05 (in relation to unstimulated cells), *p # 0.05 (in relation to NK cells from healthy individuals). (I) Dosage of granulysin in supernatants of culture of NK cells from controls (C) or PCM patients supplemented with recombinant IL-15 (5 ng/ml). The values are expressed as micromolars of granulysin. Values represent the mean 6 SEM. Statistical analysis: paired t test. p values are shown in the graphics. (J) Analysis of the effect of recombinant granulysin on P. brasiliensis yeast cells (Pb18 or Pb265 strain). Yeast cells were incubated with the indicated concentrations of granulysin at 37˚C for 48 h. After incubation, the samples were diluted 1:100 with distilled water and spread on BHI agar plates, and after 5–10 d the number of CFUs was determined. The results shown are represented as mean 6 SEM of three independent experiments. (K) Representative image of Western blotting analysis of supernatants from IL-15–stimulated NK cells untreated (Ctrl) or depleted of granulysin by immunoprecipitation (GNL-D). Membranes were labeled with specific Abs against granulysin, perforin, granzyme B, and actin. (L) Number of CFU/ml of P. brasiliensis (strain Pb18) cultured for 48 h with supernatants from IL-15–stimulated NK cells untreated (Ctrl) or depleted of granulysin by immunoprecipitation (GNL-D) or RPMI. Results expressed as mean 6 SEM of the number of CFU/ml. Statistical analysis: ANOVA test with Bonferroni posttest. *p # 0.05 (in relation to the GNL-D supernatants or RPMI). (M–P) Immunohistochemical analysis of granulysin+ cells (M), granzyme B+ cells (N), and perforin+ cells (O) (brown-stained cells) in a representative biopsy lesion from a patient with PCM. Cells were stained using specific mAbs as described in the Materials and Methods. Note that positive cells were found surrounding P. brasiliensis yeast cells (arrows). (P) Representative result of a control slide (without the primary Ab). Original magnification (M–P) 31000.
Human Granulysin, supplied by R&D Systems, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+granulysin/Recombinant+Human+Granulysin+Protein%2C+CF/pm22723518-121-47-49
Average 91 stars, based on 1 article reviews
human granulysin - by Bioz Stars, 2026-10
91/100 stars
  Buy from Supplier

94
R&D Systems 15 kda recombinant granulysin
FIGURE 4. Expression of cytotoxic granules’ components (mRNA and protein) by NK cells. (A–D) Analysis by qRT-PCR of the mRNA relative ex- pression for granzyme A (A), granzyme B (B), perforin (C), and <t>granulysin</t> (D) in NK cells isolated from peripheral blood of controls (n = 9) unstimulated (US), stimulated with IL-15 (5 ng/ml) or with P. brasiliensis yeast cells (strains Pb18 or Pb265; yeast cell/NK cell ratio 1:100) for 24 h. Results are expressed as mean 6 SEM of the relative expression determined as described in Materials and Methods. Statistical analysis: ANOVA for repeated measures with Bonferroni posttest. *p # 0.05 (in relation to unstimulated cells), #p # 0.05 (in relation to IL-15–stimulated cells). (E–H) Flow cytometry analysis of the expression of granzyme A (E), granzyme B (F), perforin (G), and granulysin (H) in NK cells isolated from peripheral blood of controls (n = 10) and PCM patients (n = 7) unstimulated (US), stimulated with IL-15 (5 ng/ml) or with P. brasiliensis yeast cells (strains Pb18 or Pb265; yeast cell/NK cell ratio 1:100) for 24 h. Results are expressed as mean 6 SEM of the percentage of positive cells for each parameter. Statistical analysis: ANOVA for repeated measures with Bonferroni posttest. #p # 0.05 (in relation to unstimulated cells), *p # 0.05 (in relation to NK cells from healthy individuals). (I) Dosage of granulysin in supernatants of culture of NK cells from controls (C) or PCM patients supplemented with recombinant IL-15 (5 ng/ml). The values are expressed as micromolars of granulysin. Values represent the mean 6 SEM. Statistical analysis: paired t test. p values are shown in the graphics. (J) Analysis of the effect of recombinant granulysin on P. brasiliensis yeast cells (Pb18 or Pb265 strain). Yeast cells were incubated with the indicated concentrations of granulysin at 37˚C for 48 h. After incubation, the samples were diluted 1:100 with distilled water and spread on BHI agar plates, and after 5–10 d the number of CFUs was determined. The results shown are represented as mean 6 SEM of three independent experiments. (K) Representative image of Western blotting analysis of supernatants from IL-15–stimulated NK cells untreated (Ctrl) or depleted of granulysin by immunoprecipitation (GNL-D). Membranes were labeled with specific Abs against granulysin, perforin, granzyme B, and actin. (L) Number of CFU/ml of P. brasiliensis (strain Pb18) cultured for 48 h with supernatants from IL-15–stimulated NK cells untreated (Ctrl) or depleted of granulysin by immunoprecipitation (GNL-D) or RPMI. Results expressed as mean 6 SEM of the number of CFU/ml. Statistical analysis: ANOVA test with Bonferroni posttest. *p # 0.05 (in relation to the GNL-D supernatants or RPMI). (M–P) Immunohistochemical analysis of granulysin+ cells (M), granzyme B+ cells (N), and perforin+ cells (O) (brown-stained cells) in a representative biopsy lesion from a patient with PCM. Cells were stained using specific mAbs as described in the Materials and Methods. Note that positive cells were found surrounding P. brasiliensis yeast cells (arrows). (P) Representative result of a control slide (without the primary Ab). Original magnification (M–P) 31000.
15 Kda Recombinant Granulysin, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+granulysin/Recombinant+Human+Granulysin+Protein%2C+CF/pm35654738-98-28-39
Average 94 stars, based on 1 article reviews
15 kda recombinant granulysin - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier

90
Becton Dickinson alexa fluor 488 anti-human granulysin (rb1
FIGURE 4. Expression of cytotoxic granules’ components (mRNA and protein) by NK cells. (A–D) Analysis by qRT-PCR of the mRNA relative ex- pression for granzyme A (A), granzyme B (B), perforin (C), and <t>granulysin</t> (D) in NK cells isolated from peripheral blood of controls (n = 9) unstimulated (US), stimulated with IL-15 (5 ng/ml) or with P. brasiliensis yeast cells (strains Pb18 or Pb265; yeast cell/NK cell ratio 1:100) for 24 h. Results are expressed as mean 6 SEM of the relative expression determined as described in Materials and Methods. Statistical analysis: ANOVA for repeated measures with Bonferroni posttest. *p # 0.05 (in relation to unstimulated cells), #p # 0.05 (in relation to IL-15–stimulated cells). (E–H) Flow cytometry analysis of the expression of granzyme A (E), granzyme B (F), perforin (G), and granulysin (H) in NK cells isolated from peripheral blood of controls (n = 10) and PCM patients (n = 7) unstimulated (US), stimulated with IL-15 (5 ng/ml) or with P. brasiliensis yeast cells (strains Pb18 or Pb265; yeast cell/NK cell ratio 1:100) for 24 h. Results are expressed as mean 6 SEM of the percentage of positive cells for each parameter. Statistical analysis: ANOVA for repeated measures with Bonferroni posttest. #p # 0.05 (in relation to unstimulated cells), *p # 0.05 (in relation to NK cells from healthy individuals). (I) Dosage of granulysin in supernatants of culture of NK cells from controls (C) or PCM patients supplemented with recombinant IL-15 (5 ng/ml). The values are expressed as micromolars of granulysin. Values represent the mean 6 SEM. Statistical analysis: paired t test. p values are shown in the graphics. (J) Analysis of the effect of recombinant granulysin on P. brasiliensis yeast cells (Pb18 or Pb265 strain). Yeast cells were incubated with the indicated concentrations of granulysin at 37˚C for 48 h. After incubation, the samples were diluted 1:100 with distilled water and spread on BHI agar plates, and after 5–10 d the number of CFUs was determined. The results shown are represented as mean 6 SEM of three independent experiments. (K) Representative image of Western blotting analysis of supernatants from IL-15–stimulated NK cells untreated (Ctrl) or depleted of granulysin by immunoprecipitation (GNL-D). Membranes were labeled with specific Abs against granulysin, perforin, granzyme B, and actin. (L) Number of CFU/ml of P. brasiliensis (strain Pb18) cultured for 48 h with supernatants from IL-15–stimulated NK cells untreated (Ctrl) or depleted of granulysin by immunoprecipitation (GNL-D) or RPMI. Results expressed as mean 6 SEM of the number of CFU/ml. Statistical analysis: ANOVA test with Bonferroni posttest. *p # 0.05 (in relation to the GNL-D supernatants or RPMI). (M–P) Immunohistochemical analysis of granulysin+ cells (M), granzyme B+ cells (N), and perforin+ cells (O) (brown-stained cells) in a representative biopsy lesion from a patient with PCM. Cells were stained using specific mAbs as described in the Materials and Methods. Note that positive cells were found surrounding P. brasiliensis yeast cells (arrows). (P) Representative result of a control slide (without the primary Ab). Original magnification (M–P) 31000.
Alexa Fluor 488 Anti Human Granulysin (Rb1, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+granulysin/alexa+fluor+488+anti+human+granulysin++rb1/pm36409085-221-42-48
Average 90 stars, based on 1 article reviews
alexa fluor 488 anti-human granulysin (rb1 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
MBL International mouse monoclonal anti-human granulysin (rb1)
Circulating <t>granulysin</t> (ng/ml) (A), perforin (pg/ml) (B), granzyme-B (pg/ml) (C) and IFN-γ (pg/ml) (D) levels before anti-TB therapy in Thai patients with HIV/TB coinfection and TB in comparison with healthy controls (HC), HIV+HAART- and HIV+HAART+. Each dot represented one individual. A horizontal bar indicated the median of each group. *, p <0.05; **, p <0.01.
Mouse Monoclonal Anti Human Granulysin (Rb1), supplied by MBL International, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+granulysin/mouse+monoclonal+anti+human+granulysin+biotinylated+rc8+mab/pmc03691799-65-14-19
Average 90 stars, based on 1 article reviews
mouse monoclonal anti-human granulysin (rb1) - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Becton Dickinson anti-human granulysin (gnly) antibody
Circulating <t>granulysin</t> (ng/ml) (A), perforin (pg/ml) (B), granzyme-B (pg/ml) (C) and IFN-γ (pg/ml) (D) levels before anti-TB therapy in Thai patients with HIV/TB coinfection and TB in comparison with healthy controls (HC), HIV+HAART- and HIV+HAART+. Each dot represented one individual. A horizontal bar indicated the median of each group. *, p <0.05; **, p <0.01.
Anti Human Granulysin (Gnly) Antibody, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+granulysin/anti+human+granulysin++gnly++antibody/pm39881000-848-0-4
Average 90 stars, based on 1 article reviews
anti-human granulysin (gnly) antibody - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

93
R&D Systems western blot for gnly
( a ) SLAY-TCS workflow. ( b ) Sort gate strategy for sort-seq, with sorting bins represented by alternating light and dark grey bars (see Supplementary Table 2 for bin edge fluorescence values). Histogram represents the results from a single biological replicate ( n = 1). ( c ) Calculated fluorescence distributions of no peptide, negative (defensin HNP-1), and positive (LL-37) control strains included in the library. Vertical lines indicate estimated mean fluorescence values for each control. ( d ) Sort-seq fold activation relative to no peptide control strains for all human AMP activators with > 2-fold activation. ( e ) Net charge and hydrophobicity, as measured by grand average of hydropathicity (GRAVY), for all human AMPs included in the screen. Human AMPs belonging to the same cluster ( Supplementary Table 1 ) are represented by a single data point with error bars indicating the median and 25 th to 75 th percentile ranges for that cluster. ( f ) Performance of the cathelicidin sparse robust linear model on peptide variants of human AMP activators of PhoPQ <t>(cathelicidin,</t> <t>CCL20,</t> hBD3, CCL19, NPY, <t>GNLY,</t> TCP) and on peptides variants of non-activating human AMPs (Other). Coefficient of determination ( r 2 ) and Pearson correlation coefficient ( r ) values were calculated for log 10 -transformed fold change and predicted fold change values.
Western Blot For Gnly, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+granulysin/Human+Granulysin+Antibody/bio_rxiv__2021__06__01__446581-370-12-16
Average 93 stars, based on 1 article reviews
western blot for gnly - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier

90
Elabscience Biotechnology human granulysin
( a ) SLAY-TCS workflow. ( b ) Sort gate strategy for sort-seq, with sorting bins represented by alternating light and dark grey bars (see Supplementary Table 2 for bin edge fluorescence values). Histogram represents the results from a single biological replicate ( n = 1). ( c ) Calculated fluorescence distributions of no peptide, negative (defensin HNP-1), and positive (LL-37) control strains included in the library. Vertical lines indicate estimated mean fluorescence values for each control. ( d ) Sort-seq fold activation relative to no peptide control strains for all human AMP activators with > 2-fold activation. ( e ) Net charge and hydrophobicity, as measured by grand average of hydropathicity (GRAVY), for all human AMPs included in the screen. Human AMPs belonging to the same cluster ( Supplementary Table 1 ) are represented by a single data point with error bars indicating the median and 25 th to 75 th percentile ranges for that cluster. ( f ) Performance of the cathelicidin sparse robust linear model on peptide variants of human AMP activators of PhoPQ <t>(cathelicidin,</t> <t>CCL20,</t> hBD3, CCL19, NPY, <t>GNLY,</t> TCP) and on peptides variants of non-activating human AMPs (Other). Coefficient of determination ( r 2 ) and Pearson correlation coefficient ( r ) values were calculated for log 10 -transformed fold change and predicted fold change values.
Human Granulysin, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+granulysin/Human+GNLY+(Granulysin)+ELISA+Kit/pm32808476-43-12-15
Average 90 stars, based on 1 article reviews
human granulysin - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Boster Bio human granulysin picokine elisa kit
( a ) SLAY-TCS workflow. ( b ) Sort gate strategy for sort-seq, with sorting bins represented by alternating light and dark grey bars (see Supplementary Table 2 for bin edge fluorescence values). Histogram represents the results from a single biological replicate ( n = 1). ( c ) Calculated fluorescence distributions of no peptide, negative (defensin HNP-1), and positive (LL-37) control strains included in the library. Vertical lines indicate estimated mean fluorescence values for each control. ( d ) Sort-seq fold activation relative to no peptide control strains for all human AMP activators with > 2-fold activation. ( e ) Net charge and hydrophobicity, as measured by grand average of hydropathicity (GRAVY), for all human AMPs included in the screen. Human AMPs belonging to the same cluster ( Supplementary Table 1 ) are represented by a single data point with error bars indicating the median and 25 th to 75 th percentile ranges for that cluster. ( f ) Performance of the cathelicidin sparse robust linear model on peptide variants of human AMP activators of PhoPQ <t>(cathelicidin,</t> <t>CCL20,</t> hBD3, CCL19, NPY, <t>GNLY,</t> TCP) and on peptides variants of non-activating human AMPs (Other). Coefficient of determination ( r 2 ) and Pearson correlation coefficient ( r ) values were calculated for log 10 -transformed fold change and predicted fold change values.
Human Granulysin Picokine Elisa Kit, supplied by Boster Bio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+granulysin/Human+Granulysin+PicoKine+Quick+ELISA+Kit/pm29896906-39-5-10
Average 90 stars, based on 1 article reviews
human granulysin picokine elisa kit - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

Image Search Results


Serum  granulysin  and cathepsin-L levels of the patient and control groups.

Journal: Revista da Associação Médica Brasileira

Article Title: Assessment of serum granulysin and cathepsin-L levels in vitiligo patients

doi: 10.1590/1806-9282.20231107

Figure Lengend Snippet: Serum granulysin and cathepsin-L levels of the patient and control groups.

Article Snippet: For the measurement of granulysin in serum, the BT LAB brand ELISA kit for human granulysin was used with a reference range of 0.5–100 ng/mL; for the measurement of cathepsin-L in serum, the BT LAB brand ELISA kit for human cathepsin-L was used with a reference range of 0.1–40 ng/mL.

Techniques: Control

Correlation between serum  granulysin  and cathepsin-L levels in the patient group.

Journal: Revista da Associação Médica Brasileira

Article Title: Assessment of serum granulysin and cathepsin-L levels in vitiligo patients

doi: 10.1590/1806-9282.20231107

Figure Lengend Snippet: Correlation between serum granulysin and cathepsin-L levels in the patient group.

Article Snippet: For the measurement of granulysin in serum, the BT LAB brand ELISA kit for human granulysin was used with a reference range of 0.5–100 ng/mL; for the measurement of cathepsin-L in serum, the BT LAB brand ELISA kit for human cathepsin-L was used with a reference range of 0.1–40 ng/mL.

Techniques:

a , Frequency of circulating lymphocytes from 8 healthy donors (HD) and 8 P. falciparum patients (Pf). CD3 + CD4 + (CD4), CD3 + CD8 + (CD8), CD3 + TCRδ2 + (γδ2), CD3 − CD56 + (NK). b , c , Circulating γδ2 T cell activation in 8 HD and 5 Pf was evaluated by CD69 and CD16 staining. d , Intracellular granulysin (GNLY), perforin (PFN) and granzyme B (GzmB) in 8 HD and 8 Pf. e , CFSE-stained iRBC were co-cultured with fresh purified γδ2 T cells from 3 HD and 3 Pf at indicated E:T ratios for 12 hr and iRBC lysis was assessed by flow cytometry analysis of the number of viable CFSE + cells relative to added counting beads. f , Plasma GNLY concentration in 16 HD and 22 Pf patients by GNLY ELISA. Statistical analysis was performed by two-tailed nonparametric unpaired t-test ( a,f ), two-way ANOVA with Sidak’s multiple comparisons test ( d ), and area under the curve, followed by two-tailed nonparametric paired t-test, followed by two-tailed nonparametric paired t-test ( e ). Mean ± s.e.m. is shown. P value: *<0.05, **<0.01, ***<0.001, ****<0.0001.

Journal: Nature immunology

Article Title: γδ T cells suppress Plasmodium falciparum blood stage infection by direct killing and phagocytosis

doi: 10.1038/s41590-020-00847-4

Figure Lengend Snippet: a , Frequency of circulating lymphocytes from 8 healthy donors (HD) and 8 P. falciparum patients (Pf). CD3 + CD4 + (CD4), CD3 + CD8 + (CD8), CD3 + TCRδ2 + (γδ2), CD3 − CD56 + (NK). b , c , Circulating γδ2 T cell activation in 8 HD and 5 Pf was evaluated by CD69 and CD16 staining. d , Intracellular granulysin (GNLY), perforin (PFN) and granzyme B (GzmB) in 8 HD and 8 Pf. e , CFSE-stained iRBC were co-cultured with fresh purified γδ2 T cells from 3 HD and 3 Pf at indicated E:T ratios for 12 hr and iRBC lysis was assessed by flow cytometry analysis of the number of viable CFSE + cells relative to added counting beads. f , Plasma GNLY concentration in 16 HD and 22 Pf patients by GNLY ELISA. Statistical analysis was performed by two-tailed nonparametric unpaired t-test ( a,f ), two-way ANOVA with Sidak’s multiple comparisons test ( d ), and area under the curve, followed by two-tailed nonparametric paired t-test, followed by two-tailed nonparametric paired t-test ( e ). Mean ± s.e.m. is shown. P value: *<0.05, **<0.01, ***<0.001, ****<0.0001.

Article Snippet: GNLY in plasma from HD and Pf patients was quantified using the Human Granulysin DuoSet ELISA (R&D Systems).

Techniques: Activation Assay, Staining, Cell Culture, Purification, Lysis, Flow Cytometry, Clinical Proteomics, Concentration Assay, Enzyme-linked Immunosorbent Assay, Two Tailed Test

a , PBMCs were stained with the Live/Dead viability dye and antibodies to CD3, CD4, CD8, TCRδ2 and CD56. Single live cells were gated on SSC-A vs FSC-A and dead cells were excluded. Lymphocyte subpopulations were gated as: CD3 + CD4 + (CD4 + T cells), CD3 + CD8 + (CD8 + T cells), CD3 + TCRδ2 + (γδ2 T cells) and CD3 − CD56 + (NK). b, PBMCs co-stained for CD69, CD16 and cytotoxic effector protein expression (GNLY, PFN and GzmB) were gated on γδ2 T cells.

Journal: Nature immunology

Article Title: γδ T cells suppress Plasmodium falciparum blood stage infection by direct killing and phagocytosis

doi: 10.1038/s41590-020-00847-4

Figure Lengend Snippet: a , PBMCs were stained with the Live/Dead viability dye and antibodies to CD3, CD4, CD8, TCRδ2 and CD56. Single live cells were gated on SSC-A vs FSC-A and dead cells were excluded. Lymphocyte subpopulations were gated as: CD3 + CD4 + (CD4 + T cells), CD3 + CD8 + (CD8 + T cells), CD3 + TCRδ2 + (γδ2 T cells) and CD3 − CD56 + (NK). b, PBMCs co-stained for CD69, CD16 and cytotoxic effector protein expression (GNLY, PFN and GzmB) were gated on γδ2 T cells.

Article Snippet: GNLY in plasma from HD and Pf patients was quantified using the Human Granulysin DuoSet ELISA (R&D Systems).

Techniques: Staining, Expressing

a-c , PBMC from HD were evaluated ex vivo (day 0) and after co-culture with uRBCs or iRBCs for 7 days. Shown are representative flow cytometry histograms (left) and percent positive cells for 4 HD samples (right) after staining for cell surface CD3 + CD4 + (CD4), CD3 + CD8 + (CD8), CD3 + TCRδ2 + (γδ2), CD3 − CD56 + (NK) and intracellular GNLY ( a ), PFN ( b ) or GzmB ( c ). The vertical gating lines were drawn based on the unstained sample. d , e , γδ2 T cell activation before and during co-culture with uRBCs or iRBCs was evaluated by CD69 and CD16 staining, n=3 independent donor samples. Statistical analysis was performed by two-way ANOVA with Sidak’s multiple comparisons test ( a-c ) and two-way ANOVA with Tukey’s multiple comparisons test ( d-e ). Mean ± s.e.m. is shown. P value: *<0.05, **<0.01,***<0.001, ****<0.0001. Data shown are representative of three independent experiments.

Journal: Nature immunology

Article Title: γδ T cells suppress Plasmodium falciparum blood stage infection by direct killing and phagocytosis

doi: 10.1038/s41590-020-00847-4

Figure Lengend Snippet: a-c , PBMC from HD were evaluated ex vivo (day 0) and after co-culture with uRBCs or iRBCs for 7 days. Shown are representative flow cytometry histograms (left) and percent positive cells for 4 HD samples (right) after staining for cell surface CD3 + CD4 + (CD4), CD3 + CD8 + (CD8), CD3 + TCRδ2 + (γδ2), CD3 − CD56 + (NK) and intracellular GNLY ( a ), PFN ( b ) or GzmB ( c ). The vertical gating lines were drawn based on the unstained sample. d , e , γδ2 T cell activation before and during co-culture with uRBCs or iRBCs was evaluated by CD69 and CD16 staining, n=3 independent donor samples. Statistical analysis was performed by two-way ANOVA with Sidak’s multiple comparisons test ( a-c ) and two-way ANOVA with Tukey’s multiple comparisons test ( d-e ). Mean ± s.e.m. is shown. P value: *<0.05, **<0.01,***<0.001, ****<0.0001. Data shown are representative of three independent experiments.

Article Snippet: GNLY in plasma from HD and Pf patients was quantified using the Human Granulysin DuoSet ELISA (R&D Systems).

Techniques: Ex Vivo, Co-Culture Assay, Flow Cytometry, Staining, Activation Assay

a-c , RBCs, incubated with indicated combinations of cytotoxic effector proteins (n=3), were assayed for RBC lysis by LDH release ( a ), parasite reinvasion into fresh RBCs by flow cytometry ( b ), and parasite morphology by electron microscopy ( c,d ). ( c ) quantifies prominent morphological alterations in EM images - parasitophorous vacuole (PV) detachment (black arrows) and increased parasite vacuolization (red arrows) in 15 images from 3 sections. Parasite nucleus (N), food vacuole (FV), hemozoin (Hz) are labeled in untreated iRBCs. e, uRBCs or unsynchronized iRBCs, stained with 25-NBD or filipin as cholesterol probes and Hoechst for parasite DNA, were analyzed by imaging flow cytometry using DNA staining to gate for different parasite stages (R ring, T trophozoite, S schizont). BF, bright field, H, Hoechst dye. f , Representative histograms (top) and quantification of multiple samples (bottom) of AF647-GNLY binding to uRBCs and iRBCs (trophozoite stage) by flow cytometry (n=5). g,h , GzmB-AF488 internalization in the absence or presence of GNLY or PFN assessed by imaging flow cytometry (n=3). ( g ) shows GzmB-AF488 (Gzm) internalization in representative images and ( h ) shows the proportion of RBCs at different parasite stages that stained for GzmB in multiple experiments, n=3. i, Representative images (left) and quantification (right) of imaging flow cytometry showing RBC, uninfected or infected at indicated parasite stage, incubated with GzmB-AF488, GNLY-AF647 and unlabeled GNLY, n=3. M, merozoite; R, ring; T, trophozoite; S, schizont; H, Hoechst dye; BF, bright field; n, biological independent samples. Scale bars: 500 nm ( d ), 7 μm ( e,g,i ). Statistical analysis was by one-way ANOVA with Tukey’s multiple comparisons test ( a,b,c,h,i ) or two-tailed nonparametric unpaired t-test ( f ). Mean ± s.e.m. is shown. P value: *<0.05, **<0.01, ***<0.001, ****<0.0001. Data shown are representative of three independent experiments.

Journal: Nature immunology

Article Title: γδ T cells suppress Plasmodium falciparum blood stage infection by direct killing and phagocytosis

doi: 10.1038/s41590-020-00847-4

Figure Lengend Snippet: a-c , RBCs, incubated with indicated combinations of cytotoxic effector proteins (n=3), were assayed for RBC lysis by LDH release ( a ), parasite reinvasion into fresh RBCs by flow cytometry ( b ), and parasite morphology by electron microscopy ( c,d ). ( c ) quantifies prominent morphological alterations in EM images - parasitophorous vacuole (PV) detachment (black arrows) and increased parasite vacuolization (red arrows) in 15 images from 3 sections. Parasite nucleus (N), food vacuole (FV), hemozoin (Hz) are labeled in untreated iRBCs. e, uRBCs or unsynchronized iRBCs, stained with 25-NBD or filipin as cholesterol probes and Hoechst for parasite DNA, were analyzed by imaging flow cytometry using DNA staining to gate for different parasite stages (R ring, T trophozoite, S schizont). BF, bright field, H, Hoechst dye. f , Representative histograms (top) and quantification of multiple samples (bottom) of AF647-GNLY binding to uRBCs and iRBCs (trophozoite stage) by flow cytometry (n=5). g,h , GzmB-AF488 internalization in the absence or presence of GNLY or PFN assessed by imaging flow cytometry (n=3). ( g ) shows GzmB-AF488 (Gzm) internalization in representative images and ( h ) shows the proportion of RBCs at different parasite stages that stained for GzmB in multiple experiments, n=3. i, Representative images (left) and quantification (right) of imaging flow cytometry showing RBC, uninfected or infected at indicated parasite stage, incubated with GzmB-AF488, GNLY-AF647 and unlabeled GNLY, n=3. M, merozoite; R, ring; T, trophozoite; S, schizont; H, Hoechst dye; BF, bright field; n, biological independent samples. Scale bars: 500 nm ( d ), 7 μm ( e,g,i ). Statistical analysis was by one-way ANOVA with Tukey’s multiple comparisons test ( a,b,c,h,i ) or two-tailed nonparametric unpaired t-test ( f ). Mean ± s.e.m. is shown. P value: *<0.05, **<0.01, ***<0.001, ****<0.0001. Data shown are representative of three independent experiments.

Article Snippet: GNLY in plasma from HD and Pf patients was quantified using the Human Granulysin DuoSet ELISA (R&D Systems).

Techniques: Incubation, Red Blood Cell Lysis, Flow Cytometry, Electron Microscopy, Labeling, Staining, Imaging, Binding Assay, Infection, Two Tailed Test

a , Electron microscopy of a ring stage iRBC treated or not with GzmB, PFN and GNLY showing disruption of morphology after treatment (right). In ( a ), parasitophorous vacuole (PV) detachment is indicated by a black arrow and increased parasite vacuolization by a red arrow. Parasite nucleus (N), hemoglobin vacuole (Hb), hemozoin (H). b , Imaging flow cytometry gating strategy for parasite developmental stages based on DNA content by Hoechst staining. M merozoites, R rings, T trophozoites, S schizonts. c, GzmB-AF488 uptake in the presence or absence of GNLY. Scale bar: 500 nm ( a ). n, biological independent samples. Data shown are representative of at least three independent experiments.

Journal: Nature immunology

Article Title: γδ T cells suppress Plasmodium falciparum blood stage infection by direct killing and phagocytosis

doi: 10.1038/s41590-020-00847-4

Figure Lengend Snippet: a , Electron microscopy of a ring stage iRBC treated or not with GzmB, PFN and GNLY showing disruption of morphology after treatment (right). In ( a ), parasitophorous vacuole (PV) detachment is indicated by a black arrow and increased parasite vacuolization by a red arrow. Parasite nucleus (N), hemoglobin vacuole (Hb), hemozoin (H). b , Imaging flow cytometry gating strategy for parasite developmental stages based on DNA content by Hoechst staining. M merozoites, R rings, T trophozoites, S schizonts. c, GzmB-AF488 uptake in the presence or absence of GNLY. Scale bar: 500 nm ( a ). n, biological independent samples. Data shown are representative of at least three independent experiments.

Article Snippet: GNLY in plasma from HD and Pf patients was quantified using the Human Granulysin DuoSet ELISA (R&D Systems).

Techniques: Electron Microscopy, Disruption, Imaging, Flow Cytometry, Staining

A: BCP-ALL cells in the presence (red) or absence (grey) of BLN for three days were co-cultured with freshly isolated γδ, CD4⁺ and CD8⁺ αβ T cells/ T- and B-cell frequencies in the coculture were assessed by staining for CD3 and CD19, as exemplary shown for CD8⁺ αβ T cells. B: The release of IFNγ, GrzB and Prf into supernatants of cocultures in the presence (red) or absence (grey) of BLN was assessed via ELISA after three days, and the release of Gnly was analyzed after seven days. Data includes 4 to 7 healthy donors and * indicates p value between 0.01-0.05, ** indicates p value between 0.01-0.001 (paired and unpaired T-test).

Journal: bioRxiv

Article Title: Blinatumomab-driven T-cell activation in αβ and γδ T-cell subsets: Insights from in vitro assays§

doi: 10.1101/2025.11.17.688178

Figure Lengend Snippet: A: BCP-ALL cells in the presence (red) or absence (grey) of BLN for three days were co-cultured with freshly isolated γδ, CD4⁺ and CD8⁺ αβ T cells/ T- and B-cell frequencies in the coculture were assessed by staining for CD3 and CD19, as exemplary shown for CD8⁺ αβ T cells. B: The release of IFNγ, GrzB and Prf into supernatants of cocultures in the presence (red) or absence (grey) of BLN was assessed via ELISA after three days, and the release of Gnly was analyzed after seven days. Data includes 4 to 7 healthy donors and * indicates p value between 0.01-0.05, ** indicates p value between 0.01-0.001 (paired and unpaired T-test).

Article Snippet: Cell culture supernatants were analyzed for Interferon-γ (IFNγ; DIF50C), Granzyme B (GrzB; DGZB00), Perforin (QK8011), Granulysin (Gnly; DY3138), Perforin (Prf; QK8011) and soluble Fas-Ligand (sFAS-L; DFL00B) using sandwich ELISA kits from R&D Systems, Minneapolis, USA according to the manufacturer’s instructions.

Techniques: Cell Culture, Isolation, Staining, Enzyme-linked Immunosorbent Assay

FIGURE 4. Expression of cytotoxic granules’ components (mRNA and protein) by NK cells. (A–D) Analysis by qRT-PCR of the mRNA relative ex- pression for granzyme A (A), granzyme B (B), perforin (C), and granulysin (D) in NK cells isolated from peripheral blood of controls (n = 9) unstimulated (US), stimulated with IL-15 (5 ng/ml) or with P. brasiliensis yeast cells (strains Pb18 or Pb265; yeast cell/NK cell ratio 1:100) for 24 h. Results are expressed as mean 6 SEM of the relative expression determined as described in Materials and Methods. Statistical analysis: ANOVA for repeated measures with Bonferroni posttest. *p # 0.05 (in relation to unstimulated cells), #p # 0.05 (in relation to IL-15–stimulated cells). (E–H) Flow cytometry analysis of the expression of granzyme A (E), granzyme B (F), perforin (G), and granulysin (H) in NK cells isolated from peripheral blood of controls (n = 10) and PCM patients (n = 7) unstimulated (US), stimulated with IL-15 (5 ng/ml) or with P. brasiliensis yeast cells (strains Pb18 or Pb265; yeast cell/NK cell ratio 1:100) for 24 h. Results are expressed as mean 6 SEM of the percentage of positive cells for each parameter. Statistical analysis: ANOVA for repeated measures with Bonferroni posttest. #p # 0.05 (in relation to unstimulated cells), *p # 0.05 (in relation to NK cells from healthy individuals). (I) Dosage of granulysin in supernatants of culture of NK cells from controls (C) or PCM patients supplemented with recombinant IL-15 (5 ng/ml). The values are expressed as micromolars of granulysin. Values represent the mean 6 SEM. Statistical analysis: paired t test. p values are shown in the graphics. (J) Analysis of the effect of recombinant granulysin on P. brasiliensis yeast cells (Pb18 or Pb265 strain). Yeast cells were incubated with the indicated concentrations of granulysin at 37˚C for 48 h. After incubation, the samples were diluted 1:100 with distilled water and spread on BHI agar plates, and after 5–10 d the number of CFUs was determined. The results shown are represented as mean 6 SEM of three independent experiments. (K) Representative image of Western blotting analysis of supernatants from IL-15–stimulated NK cells untreated (Ctrl) or depleted of granulysin by immunoprecipitation (GNL-D). Membranes were labeled with specific Abs against granulysin, perforin, granzyme B, and actin. (L) Number of CFU/ml of P. brasiliensis (strain Pb18) cultured for 48 h with supernatants from IL-15–stimulated NK cells untreated (Ctrl) or depleted of granulysin by immunoprecipitation (GNL-D) or RPMI. Results expressed as mean 6 SEM of the number of CFU/ml. Statistical analysis: ANOVA test with Bonferroni posttest. *p # 0.05 (in relation to the GNL-D supernatants or RPMI). (M–P) Immunohistochemical analysis of granulysin+ cells (M), granzyme B+ cells (N), and perforin+ cells (O) (brown-stained cells) in a representative biopsy lesion from a patient with PCM. Cells were stained using specific mAbs as described in the Materials and Methods. Note that positive cells were found surrounding P. brasiliensis yeast cells (arrows). (P) Representative result of a control slide (without the primary Ab). Original magnification (M–P) 31000.

Journal: Journal of immunology (Baltimore, Md. : 1950)

Article Title: Phenotypic and functional characterization of NK cells in human immune response against the dimorphic fungus Paracoccidioides brasiliensis.

doi: 10.4049/jimmunol.1102563

Figure Lengend Snippet: FIGURE 4. Expression of cytotoxic granules’ components (mRNA and protein) by NK cells. (A–D) Analysis by qRT-PCR of the mRNA relative ex- pression for granzyme A (A), granzyme B (B), perforin (C), and granulysin (D) in NK cells isolated from peripheral blood of controls (n = 9) unstimulated (US), stimulated with IL-15 (5 ng/ml) or with P. brasiliensis yeast cells (strains Pb18 or Pb265; yeast cell/NK cell ratio 1:100) for 24 h. Results are expressed as mean 6 SEM of the relative expression determined as described in Materials and Methods. Statistical analysis: ANOVA for repeated measures with Bonferroni posttest. *p # 0.05 (in relation to unstimulated cells), #p # 0.05 (in relation to IL-15–stimulated cells). (E–H) Flow cytometry analysis of the expression of granzyme A (E), granzyme B (F), perforin (G), and granulysin (H) in NK cells isolated from peripheral blood of controls (n = 10) and PCM patients (n = 7) unstimulated (US), stimulated with IL-15 (5 ng/ml) or with P. brasiliensis yeast cells (strains Pb18 or Pb265; yeast cell/NK cell ratio 1:100) for 24 h. Results are expressed as mean 6 SEM of the percentage of positive cells for each parameter. Statistical analysis: ANOVA for repeated measures with Bonferroni posttest. #p # 0.05 (in relation to unstimulated cells), *p # 0.05 (in relation to NK cells from healthy individuals). (I) Dosage of granulysin in supernatants of culture of NK cells from controls (C) or PCM patients supplemented with recombinant IL-15 (5 ng/ml). The values are expressed as micromolars of granulysin. Values represent the mean 6 SEM. Statistical analysis: paired t test. p values are shown in the graphics. (J) Analysis of the effect of recombinant granulysin on P. brasiliensis yeast cells (Pb18 or Pb265 strain). Yeast cells were incubated with the indicated concentrations of granulysin at 37˚C for 48 h. After incubation, the samples were diluted 1:100 with distilled water and spread on BHI agar plates, and after 5–10 d the number of CFUs was determined. The results shown are represented as mean 6 SEM of three independent experiments. (K) Representative image of Western blotting analysis of supernatants from IL-15–stimulated NK cells untreated (Ctrl) or depleted of granulysin by immunoprecipitation (GNL-D). Membranes were labeled with specific Abs against granulysin, perforin, granzyme B, and actin. (L) Number of CFU/ml of P. brasiliensis (strain Pb18) cultured for 48 h with supernatants from IL-15–stimulated NK cells untreated (Ctrl) or depleted of granulysin by immunoprecipitation (GNL-D) or RPMI. Results expressed as mean 6 SEM of the number of CFU/ml. Statistical analysis: ANOVA test with Bonferroni posttest. *p # 0.05 (in relation to the GNL-D supernatants or RPMI). (M–P) Immunohistochemical analysis of granulysin+ cells (M), granzyme B+ cells (N), and perforin+ cells (O) (brown-stained cells) in a representative biopsy lesion from a patient with PCM. Cells were stained using specific mAbs as described in the Materials and Methods. Note that positive cells were found surrounding P. brasiliensis yeast cells (arrows). (P) Representative result of a control slide (without the primary Ab). Original magnification (M–P) 31000.

Article Snippet: The dosage of granulysin in supernatants of NK cells cultured with P. brasiliensis yeast cells stimulated or not with rhIL-15 was performed by ELISA as previously described (18), and the results are expressed as micromolars of granulysin determined by comparison with a standard curve made of recombinant human granulysin (R&D Systems).

Techniques: Expressing, Quantitative RT-PCR, Isolation, Flow Cytometry, Recombinant, Incubation, Western Blot, Immunoprecipitation, Labeling, Cell Culture, Immunohistochemical staining, Staining, Control

Circulating granulysin (ng/ml) (A), perforin (pg/ml) (B), granzyme-B (pg/ml) (C) and IFN-γ (pg/ml) (D) levels before anti-TB therapy in Thai patients with HIV/TB coinfection and TB in comparison with healthy controls (HC), HIV+HAART- and HIV+HAART+. Each dot represented one individual. A horizontal bar indicated the median of each group. *, p <0.05; **, p <0.01.

Journal: International Journal of Medical Sciences

Article Title: Potential Function of Granulysin, Other Related Effector Molecules and Lymphocyte Subsets in Patients with TB and HIV/TB Coinfection

doi: 10.7150/ijms.6437

Figure Lengend Snippet: Circulating granulysin (ng/ml) (A), perforin (pg/ml) (B), granzyme-B (pg/ml) (C) and IFN-γ (pg/ml) (D) levels before anti-TB therapy in Thai patients with HIV/TB coinfection and TB in comparison with healthy controls (HC), HIV+HAART- and HIV+HAART+. Each dot represented one individual. A horizontal bar indicated the median of each group. *, p <0.05; **, p <0.01.

Article Snippet: Briefly, a microtiter plate (Costar, USA) was coated with 100 μl/well containing 5 μg/ml mouse monoclonal anti-human granulysin (RB1) (MBL International Corporation, Nagoya, Japan) in 0.05 M carbonate-bicarbonate buffer (pH 9.5) and incubated overnight at 4 o C. The plates were washed with phosphate buffered saline (PBS) containing 0.05% Tween 20 and blocked with buffered protein solution with ProClin-150 at room temperature (RT) for 1 h. After being washed, the undiluted plasma was added and incubated for 2 h at RT and followed by washing.

Techniques: Comparison

Levels of circulating  granulysin,  perforin, granzyme-B and IFN-γ and number of effector cells in patients with HIV/TB coinfection before anti-TB therapy.

Journal: International Journal of Medical Sciences

Article Title: Potential Function of Granulysin, Other Related Effector Molecules and Lymphocyte Subsets in Patients with TB and HIV/TB Coinfection

doi: 10.7150/ijms.6437

Figure Lengend Snippet: Levels of circulating granulysin, perforin, granzyme-B and IFN-γ and number of effector cells in patients with HIV/TB coinfection before anti-TB therapy.

Article Snippet: Briefly, a microtiter plate (Costar, USA) was coated with 100 μl/well containing 5 μg/ml mouse monoclonal anti-human granulysin (RB1) (MBL International Corporation, Nagoya, Japan) in 0.05 M carbonate-bicarbonate buffer (pH 9.5) and incubated overnight at 4 o C. The plates were washed with phosphate buffered saline (PBS) containing 0.05% Tween 20 and blocked with buffered protein solution with ProClin-150 at room temperature (RT) for 1 h. After being washed, the undiluted plasma was added and incubated for 2 h at RT and followed by washing.

Techniques:

Isoforms of granulysin expression in plasma from Thai patients by Western blot analysis. Lane 1-3, HIV/TB coinfection plasma, 3 bands of ∼17kDa, 15kDa and 9kDa isoforms; Lanes: 4-6, TB plasma, I band of ∼17kDa isoform (Lane 4) and 2 bands of ∼15kDa and 9kDa isoforms (Lane 5-6); Lane 7, 2 bands of HC ∼15kDa and 9kDa isoforms.

Journal: International Journal of Medical Sciences

Article Title: Potential Function of Granulysin, Other Related Effector Molecules and Lymphocyte Subsets in Patients with TB and HIV/TB Coinfection

doi: 10.7150/ijms.6437

Figure Lengend Snippet: Isoforms of granulysin expression in plasma from Thai patients by Western blot analysis. Lane 1-3, HIV/TB coinfection plasma, 3 bands of ∼17kDa, 15kDa and 9kDa isoforms; Lanes: 4-6, TB plasma, I band of ∼17kDa isoform (Lane 4) and 2 bands of ∼15kDa and 9kDa isoforms (Lane 5-6); Lane 7, 2 bands of HC ∼15kDa and 9kDa isoforms.

Article Snippet: Briefly, a microtiter plate (Costar, USA) was coated with 100 μl/well containing 5 μg/ml mouse monoclonal anti-human granulysin (RB1) (MBL International Corporation, Nagoya, Japan) in 0.05 M carbonate-bicarbonate buffer (pH 9.5) and incubated overnight at 4 o C. The plates were washed with phosphate buffered saline (PBS) containing 0.05% Tween 20 and blocked with buffered protein solution with ProClin-150 at room temperature (RT) for 1 h. After being washed, the undiluted plasma was added and incubated for 2 h at RT and followed by washing.

Techniques: Expressing, Clinical Proteomics, Western Blot

Circulating granulysin (ng/ml) and IFN-γ (pg/ml) in Thai patients with HIV/TB coinfection (A and C) and patients with TB (B and D) before and after completion of anti-TB therapy. Each dot represented one individual. *, p <0.05.

Journal: International Journal of Medical Sciences

Article Title: Potential Function of Granulysin, Other Related Effector Molecules and Lymphocyte Subsets in Patients with TB and HIV/TB Coinfection

doi: 10.7150/ijms.6437

Figure Lengend Snippet: Circulating granulysin (ng/ml) and IFN-γ (pg/ml) in Thai patients with HIV/TB coinfection (A and C) and patients with TB (B and D) before and after completion of anti-TB therapy. Each dot represented one individual. *, p <0.05.

Article Snippet: Briefly, a microtiter plate (Costar, USA) was coated with 100 μl/well containing 5 μg/ml mouse monoclonal anti-human granulysin (RB1) (MBL International Corporation, Nagoya, Japan) in 0.05 M carbonate-bicarbonate buffer (pH 9.5) and incubated overnight at 4 o C. The plates were washed with phosphate buffered saline (PBS) containing 0.05% Tween 20 and blocked with buffered protein solution with ProClin-150 at room temperature (RT) for 1 h. After being washed, the undiluted plasma was added and incubated for 2 h at RT and followed by washing.

Techniques:

Circulating granulysin (ng/ml) in Japanese patients with HIV/TB coinfection before anti-TB therapy, HIV+HAART- and healthy controls (HC). Each dot represented one individual. A horizontal bar indicated the median of each group. *, p <0.05.

Journal: International Journal of Medical Sciences

Article Title: Potential Function of Granulysin, Other Related Effector Molecules and Lymphocyte Subsets in Patients with TB and HIV/TB Coinfection

doi: 10.7150/ijms.6437

Figure Lengend Snippet: Circulating granulysin (ng/ml) in Japanese patients with HIV/TB coinfection before anti-TB therapy, HIV+HAART- and healthy controls (HC). Each dot represented one individual. A horizontal bar indicated the median of each group. *, p <0.05.

Article Snippet: Briefly, a microtiter plate (Costar, USA) was coated with 100 μl/well containing 5 μg/ml mouse monoclonal anti-human granulysin (RB1) (MBL International Corporation, Nagoya, Japan) in 0.05 M carbonate-bicarbonate buffer (pH 9.5) and incubated overnight at 4 o C. The plates were washed with phosphate buffered saline (PBS) containing 0.05% Tween 20 and blocked with buffered protein solution with ProClin-150 at room temperature (RT) for 1 h. After being washed, the undiluted plasma was added and incubated for 2 h at RT and followed by washing.

Techniques:

( a ) SLAY-TCS workflow. ( b ) Sort gate strategy for sort-seq, with sorting bins represented by alternating light and dark grey bars (see Supplementary Table 2 for bin edge fluorescence values). Histogram represents the results from a single biological replicate ( n = 1). ( c ) Calculated fluorescence distributions of no peptide, negative (defensin HNP-1), and positive (LL-37) control strains included in the library. Vertical lines indicate estimated mean fluorescence values for each control. ( d ) Sort-seq fold activation relative to no peptide control strains for all human AMP activators with > 2-fold activation. ( e ) Net charge and hydrophobicity, as measured by grand average of hydropathicity (GRAVY), for all human AMPs included in the screen. Human AMPs belonging to the same cluster ( Supplementary Table 1 ) are represented by a single data point with error bars indicating the median and 25 th to 75 th percentile ranges for that cluster. ( f ) Performance of the cathelicidin sparse robust linear model on peptide variants of human AMP activators of PhoPQ (cathelicidin, CCL20, hBD3, CCL19, NPY, GNLY, TCP) and on peptides variants of non-activating human AMPs (Other). Coefficient of determination ( r 2 ) and Pearson correlation coefficient ( r ) values were calculated for log 10 -transformed fold change and predicted fold change values.

Journal: bioRxiv

Article Title: High-throughput discovery of peptide activators of a bacterial sensor kinase

doi: 10.1101/2021.06.01.446581

Figure Lengend Snippet: ( a ) SLAY-TCS workflow. ( b ) Sort gate strategy for sort-seq, with sorting bins represented by alternating light and dark grey bars (see Supplementary Table 2 for bin edge fluorescence values). Histogram represents the results from a single biological replicate ( n = 1). ( c ) Calculated fluorescence distributions of no peptide, negative (defensin HNP-1), and positive (LL-37) control strains included in the library. Vertical lines indicate estimated mean fluorescence values for each control. ( d ) Sort-seq fold activation relative to no peptide control strains for all human AMP activators with > 2-fold activation. ( e ) Net charge and hydrophobicity, as measured by grand average of hydropathicity (GRAVY), for all human AMPs included in the screen. Human AMPs belonging to the same cluster ( Supplementary Table 1 ) are represented by a single data point with error bars indicating the median and 25 th to 75 th percentile ranges for that cluster. ( f ) Performance of the cathelicidin sparse robust linear model on peptide variants of human AMP activators of PhoPQ (cathelicidin, CCL20, hBD3, CCL19, NPY, GNLY, TCP) and on peptides variants of non-activating human AMPs (Other). Coefficient of determination ( r 2 ) and Pearson correlation coefficient ( r ) values were calculated for log 10 -transformed fold change and predicted fold change values.

Article Snippet: Macrophage cell lysates were collected at 4 h post-infection and subjected to Western blot for GNLY (R&D Systems Cat# AF3138-SP), CCL20 (R&D Systems Cat# AF360-SP), and/or actin (Abcam Cat# 179467) using 40 μg of total protein.

Techniques: Fluorescence, Control, Activation Assay, Transformation Assay